The US Food and Drug Administration recently released a draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and conduct of clinical trials.
Probiota Americas is just over two weeks away. With key scientific insights into the category’s most disruptive technology – A.I., CRISPR, and -omics – and a look at the microbiomes of centenarians, don’t wait to register!
A randomized, triple-blind, placebo-controlled clinical trial involving supplementation with UP360 provides evidence for a robust, healthy immune response in healthy adults following influenza. | May 3, 2023
Today we can reveal the first wave of speakers confirmed for Probiota Americas, the must-attend conference bridging the business and science of microbiome modulation for human health.
Hofseth BioCare ASA is yet again part of an Exclusive Short-List of Companies to Have Successfully Notified FDA while receiving a No Objection Letter for.